Unusual presentation of pulmonary tumor thrombotic microangiopathy with no detectable primary tumor
- PMID: 19242078
- DOI: 10.4103/0022-3859.48439
Unusual presentation of pulmonary tumor thrombotic microangiopathy with no detectable primary tumor
Abstract
Pulmonary tumor thrombotic microangiopathy (PTTM) is a rare condition characterized by the presence of diffuse thrombotic microthrombi and fibrocellular intimal proliferation in the pulmonary vasculature. Its development is linked to the presence of pulmonary tumor microemboli (PTM) and should be suspected in patients with unexplained dyspnea, especially in the presence of adenocarcinoma. PTTM presents in a similar fashion to respiratory disease such as pulmonary embolism, pulmonary hypertension or pneumonia and is usually only diagnosed post-mortem. We report a case of PTTM identified ante-mortem by bronchial biopsy in an 82-year-old woman presenting with a clinical picture of atypical pneumonia. Autopsy confirmed PTTM, from an unknown primary neoplasm.
Similar articles
-
Pulmonary tumor thrombotic microangiopathy.Pathol Int. 1995 Jun;45(6):436-40. doi: 10.1111/j.1440-1827.1995.tb03481.x. Pathol Int. 1995. PMID: 7581935
-
A microscopic adenocarcinoma of the stomach with pulmonary tumor thrombotic microangiopathy in a 17-year-old male.Pathol Res Pract. 2005;201(6):457-61. doi: 10.1016/j.prp.2005.05.002. Pathol Res Pract. 2005. PMID: 16136752 Review.
-
Pulmonary tumor thrombotic microangiopathy from metastatic gallbladder carcinoma: an unusual cause of severe pulmonary hypertension.Dig Dis Sci. 2007 Feb;52(2):555-7. doi: 10.1007/s10620-006-9232-z. Epub 2007 Jan 12. Dig Dis Sci. 2007. PMID: 17219075
-
Pulmonary tumor thrombotic microangiopathy caused by an ovarian cancer expressing tissue factor and vascular endothelial growth factor.Pathol Res Pract. 2009;205(1):63-8. doi: 10.1016/j.prp.2008.08.002. Epub 2008 Oct 2. Pathol Res Pract. 2009. PMID: 18835104
-
Pulmonary tumor thrombotic microangiopathy: the challenge of the antemortem diagnosis.J Cardiovasc Med (Hagerstown). 2014 Nov;15(11):828-33. doi: 10.2459/JCM.0b013e328354e473. J Cardiovasc Med (Hagerstown). 2014. PMID: 22710763 Review.
Cited by
-
Platelet-derived growth factor-A and vascular endothelial growth factor-C contribute to the development of pulmonary tumor thrombotic microangiopathy in gastric cancer.Virchows Arch. 2013 May;462(5):523-31. doi: 10.1007/s00428-013-1403-7. Epub 2013 Mar 28. Virchows Arch. 2013. PMID: 23536282
-
Pulmonary tumor thrombotic microangiopathy: a systematic review.Pulm Circ. 2019 Apr-Jun;9(2):2045894019851000. doi: 10.1177/2045894019851000. Pulm Circ. 2019. PMID: 31032740 Free PMC article.
-
Improvement of Breast Cancer-Associated Pulmonary Tumor Thrombotic Microangiopathy With Carboplatin and Gemcitabine.Cureus. 2023 May 5;15(5):e38600. doi: 10.7759/cureus.38600. eCollection 2023 May. Cureus. 2023. PMID: 37284356 Free PMC article.
-
Pulmonary tumor thrombotic microangiopathy associated with lung cancer.J Cardiol Cases. 2009 Dec 2;1(2):e120-e123. doi: 10.1016/j.jccase.2009.10.005. eCollection 2010 Apr. J Cardiol Cases. 2009. PMID: 30615772 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical